These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


79 related items for PubMed ID: 7100251

  • 1. Retard implantation tablets on a matrix base with Eudragit as a structural substance.
    Korsatko W.
    Pharmazie; 1982 Apr; 37(4):272-3. PubMed ID: 7100251
    [Abstract] [Full Text] [Related]

  • 2. [Control of drug release from coated parenteral matrix-retard tablets using softening agents].
    Korsatko W, Wabnegg B.
    Pharmazie; 1983 Sep; 38(9):608-11. PubMed ID: 6647533
    [Abstract] [Full Text] [Related]

  • 3. The influence of Eudragit type on the dissolution rate of acetylsalicylic acid from matrix tablets.
    Jovanović M, Jovicić G, Djurić Z, Agbaba D, Karljiković-Rajić K, Nikolić L, Radovanović J.
    Acta Pharm Hung; 1997 Nov; 67(6):229-34. PubMed ID: 9423294
    [Abstract] [Full Text] [Related]

  • 4. Development of matrix-based theophylline sustained-release microtablets.
    Rey H, Wagner KG, Wehrlé P, Schmidt PC.
    Drug Dev Ind Pharm; 2000 Jan; 26(1):21-6. PubMed ID: 10677806
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Combination of time-dependent and pH-dependent polymethacrylates as a single coating formulation for colonic delivery of indomethacin pellets.
    Akhgari A, Sadeghi F, Garekani HA.
    Int J Pharm; 2006 Aug 31; 320(1-2):137-42. PubMed ID: 16782290
    [Abstract] [Full Text] [Related]

  • 11. Floating hot-melt extruded tablets for gastroretentive controlled drug release system.
    Fukuda M, Peppas NA, McGinity JW.
    J Control Release; 2006 Oct 10; 115(2):121-9. PubMed ID: 16959356
    [Abstract] [Full Text] [Related]

  • 12. [Conditions for applying enteric coatings based on Eudragit L 30 D].
    Dechesne JP, Delporte JP, Jaminet F, Venturas K.
    J Pharm Belg; 1982 Oct 10; 37(4):273-82. PubMed ID: 7143200
    [No Abstract] [Full Text] [Related]

  • 13. Colonic release and reduced intestinal tissue damage of coated tablets containing naproxen inclusion complex.
    Piao ZZ, Lee MK, Lee BJ.
    Int J Pharm; 2008 Feb 28; 350(1-2):205-11. PubMed ID: 17928177
    [Abstract] [Full Text] [Related]

  • 14. A comparative in vitro assessment of the drug release performance of pH-responsive polymers for ileo-colonic delivery.
    Ibekwe VC, Fadda HM, Parsons GE, Basit AW.
    Int J Pharm; 2006 Feb 03; 308(1-2):52-60. PubMed ID: 16356670
    [Abstract] [Full Text] [Related]

  • 15. Influence of methacrylic acid and hydroxypropylmethyl cellulose on the tablet properties and in vitro release of dextromethorphan hydrobromide.
    Takka S, Singh Bharaj S, Sakr A.
    Pharmazie; 2003 Dec 03; 58(12):886-90. PubMed ID: 14703967
    [Abstract] [Full Text] [Related]

  • 16. Crystal growth formation in melt extrudates.
    Bruce C, Fegely KA, Rajabi-Siahboomi AR, McGinity JW.
    Int J Pharm; 2007 Aug 16; 341(1-2):162-72. PubMed ID: 17524578
    [Abstract] [Full Text] [Related]

  • 17. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
    Dukić-Ott A, De Beer T, Remon JP, Baeyens W, Foreman P, Vervaet C.
    Eur J Pharm Biopharm; 2008 Sep 16; 70(1):302-12. PubMed ID: 18579353
    [Abstract] [Full Text] [Related]

  • 18. Eudragit matrices for sustained release of ketorolac tromethamine: formulation and kinetics of release.
    Ruckmani K, Muneera MS, Vijaya R.
    Boll Chim Farm; 2000 Sep 16; 139(5):205-8. PubMed ID: 11213438
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Relationship between drug dissolution and leaching of plasticizer for pellets coated with an aqueous Eudragit S100:L100 dispersion.
    Bando H, McGinity JW.
    Int J Pharm; 2006 Oct 12; 323(1-2):11-7. PubMed ID: 16815652
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 4.